Table. 1.

Patient demographics

Total (n = 353) No DM after PD (n = 178) New-onset DM after PD (n = 64) p-valuea)
Age (yr) 65.4 ± 10.3 65.0 ± 10.5 63.5 ± 11.0 0.327
Sex 0.461
Male 205 (58.1) 99 (55.6) 39 (60.9)
Female 148 (41.9) 79 (44.4) 25 (39.1)
Preoperative body mass index (kg/m2) 23.2 ± 3.3 23.1 ± 3.1 23.2 ± 3.1 0.893
ASA classification 0.109
1 34 (9.6) 25 (14.0) 7 (10.9)
2 296 (83.9) 146 (82.0) 50 (78.1)
3 23 (6.5) 7 (3.9) 7 (10.9)
Preoperative DM 111 (31.4) 0 (0) 0 (0)
Preoperative hypertension 164 (46.5) 107 (60.1) 38 (59.4) 0.918
Origin of neoplasm 0.812
Pancreas 173 (49.0) 81 (45.5) 33 (51.6)
Common bile duct 96 (27.2) 44 (24.7) 12 (18.8)
Ampulla of Vater 65 (18.4) 38 (21.3) 12 (18.8)
Duodenum 19 (5.4) 11 (6.2) 5 (3.1)

Values are expressed as means ± standard deviations or number (%).

ASA, American Society of Anesthesiologist; DM, diabetes mellitus; PD, pancreaticoduodenectomy.

a)p-value was calculated through comparison between the ‘No DM after PD’ and ‘New-onset DM after PD’ groups.

Ann Hepatobiliary Pancreat Surg 2024;28:364-70 https://doi.org/10.14701/ahbps.24-004
© 2024 Ann Hepatobiliary Pancreat Surg